RxDoctor Payments Data

Andre Reed, MD

Otolaryngology · Englewood, CONPI 1003885393

Payments from drug & device makers

$541in general payments, 2019–2025

Across 26 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$166
  • Takeda Pharmaceuticals U.S.A., Inc.$87
  • Johnson & Johnson$72
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$37
  • Davol Inc.$30
  • Bard Peripheral Vascular, Inc.$29
  • plus $120 from 6 others

What the payments were for

  • Food & beverage$541100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$541 in reported general payments places this provider in the 35th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$121,887
Medicare patients
232
Services billed
1,067

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole763$10,662
Lansoprazole57$1,568
Nystatin83$1,495
Famotidine99$1,143
Pantoprazole Sodium31$390
Fluconazole23$343
Fluticasone Propionate11$255
Azithromycin21$76

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →